Categories: Tech

Exterro Joins AWS ISV Accelerate Program

COIMBATORE, India, Nov. 5, 2025 /PRNewswire/ — Exterro, the leading provider of data risk management software, today announced that it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS Partners that provides software solutions that run on or integrate with AWS. The program helps AWS Partners drive new business by directly connecting participating ISVs with the AWS Sales organization.

- Advertisement -

Exterro’s Data Risk Management platform empowers organizations to identify, understand, and manage their data wherever it resides—helping legal, privacy, compliance, and digital forensics teams reduce risk, accelerate investigations, and ensure regulatory compliance. With its availability as part of the AWS ISV Accelerate Program, enterprise customers now have easier access to the Exterro platform to help transform workflows such as:

- Advertisement -
  • Legal hold management
  • Document review
  • Internal investigations
  • Data mapping and categorization
  • Incident response

The Exterro solution enables enterprises to orchestrate and automate workflows by leveraging responsible AI and its Exterro Intelligence to accelerate insights and achieve measurable savings in both time and cost.

- Advertisement -

“By joining the AWS ISV Accelerate Program, we’re expanding customers’ access to our AI-powered, enterprise-scale data risk management platform, which includes our eDiscovery and document review to data privacy, security, governance and digital forensics solutions,” said Bruce Holbert, Senior Director, Channel Sales at Exterro. “Working with AWS aligns with our commitment to build strategic collaborations that make it easier for customers to manage and secure their data wherever it resides.”

- Advertisement -

The AWS ISV Accelerate Program provides Exterro with co-sell support and benefits to meet customer needs through collaboration with AWS field sellers globally. Co-selling provides better customer outcomes and assures mutual commitment from AWS and its partners.

- Advertisement -

AWS ISV Accelerate Program members are held to the industry’s highest standards and must undergo a comprehensive evaluation to gain acceptance into the program. Exterro participated in a thorough architectural and security review to ensure the quality and design of its solutions. Proof of customer excellence was also reviewed to validate the successes Exterro customers have achieved across industry verticals.

- Advertisement -

Exterro’s solutions are available globally. To learn more, visit here.

- Advertisement -

About Exterro

- Advertisement -

Exterro empowers organizations to manage data risks with a complete platform for e-discovery, data privacy, cybersecurity and governance, and digital forensics. Unlike any other software provider, Exterro makes it easy for organizations to understand their data and take swift action. Exterro’s AI-driven solutions provide accurate, actionable insights, enabling businesses to ensure compliance, reduce risks, and streamline operations while lowering costs. With Exterro, organizations gain the clarity and confidence needed to address their most critical data challenges. For more information, visit www.exterro.com

- Advertisement -

Photo: https://mma.prnewswire.com/media/2814130/Exterro_Joins_AWS.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/exterro-joins-aws-isv-accelerate-program-302605131.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

4 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago